nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—Abdominal distress—Methotrexate—esophageal cancer	0.00703	0.0439	CcSEcCtD
Metformin—Angina unstable—Capecitabine—esophageal cancer	0.00506	0.0316	CcSEcCtD
Metformin—Tonsillitis—Capecitabine—esophageal cancer	0.00506	0.0316	CcSEcCtD
Metformin—Anaemia megaloblastic—Methotrexate—esophageal cancer	0.00404	0.0252	CcSEcCtD
Metformin—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.00358	0.0224	CcSEcCtD
Metformin—ND4—neck—esophageal cancer	0.0034	0.00734	CbGeAlD
Metformin—NDUFB2—neck—esophageal cancer	0.00312	0.00674	CbGeAlD
Metformin—ND6—neck—esophageal cancer	0.00307	0.00663	CbGeAlD
Metformin—Tooth abscess—Capecitabine—esophageal cancer	0.00306	0.0191	CcSEcCtD
Metformin—Taste metallic—Methotrexate—esophageal cancer	0.00299	0.0187	CcSEcCtD
Metformin—NDUFA5—neck—esophageal cancer	0.00298	0.00642	CbGeAlD
Metformin—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.00285	0.0178	CcSEcCtD
Metformin—NDUFS4—neck—esophageal cancer	0.00281	0.00607	CbGeAlD
Metformin—NDUFB4—neck—esophageal cancer	0.00278	0.00599	CbGeAlD
Metformin—NDUFA4—neck—esophageal cancer	0.00273	0.00588	CbGeAlD
Metformin—NDUFV1—neck—esophageal cancer	0.00271	0.00585	CbGeAlD
Metformin—NDUFS5—neck—esophageal cancer	0.00269	0.00581	CbGeAlD
Metformin—ND1—exocrine gland—esophageal cancer	0.00268	0.00579	CbGeAlD
Metformin—NDUFS6—digestive system—esophageal cancer	0.00255	0.00551	CbGeAlD
Metformin—NDUFA4L2—bronchus—esophageal cancer	0.0025	0.0054	CbGeAlD
Metformin—NDUFAF3—digestive system—esophageal cancer	0.00232	0.00501	CbGeAlD
Metformin—ND3—smooth muscle tissue—esophageal cancer	0.0023	0.00497	CbGeAlD
Metformin—ND2—smooth muscle tissue—esophageal cancer	0.0023	0.00497	CbGeAlD
Metformin—ND5—smooth muscle tissue—esophageal cancer	0.0023	0.00497	CbGeAlD
Metformin—ND4L—smooth muscle tissue—esophageal cancer	0.0023	0.00497	CbGeAlD
Metformin—NDUFA4L2—trachea—esophageal cancer	0.00225	0.00485	CbGeAlD
Metformin—NDUFA2—bronchus—esophageal cancer	0.00223	0.00482	CbGeAlD
Metformin—ND4—smooth muscle tissue—esophageal cancer	0.00223	0.00481	CbGeAlD
Metformin—NDUFA2—smooth muscle tissue—esophageal cancer	0.00218	0.00471	CbGeAlD
Metformin—NDUFC2—neck—esophageal cancer	0.00218	0.0047	CbGeAlD
Metformin—Rhinorrhoea—Cisplatin—esophageal cancer	0.00214	0.0134	CcSEcCtD
Metformin—NDUFS6—lung—esophageal cancer	0.00213	0.0046	CbGeAlD
Metformin—NDUFA10—bronchus—esophageal cancer	0.00213	0.00459	CbGeAlD
Metformin—NDUFC1—bronchus—esophageal cancer	0.00211	0.00455	CbGeAlD
Metformin—Infection—Carboplatin—esophageal cancer	0.0021	0.0131	CcSEcCtD
Metformin—NDUFB2—bronchus—esophageal cancer	0.00209	0.00452	CbGeAlD
Metformin—NDUFA10—smooth muscle tissue—esophageal cancer	0.00208	0.0045	CbGeAlD
Metformin—NDUFA13—digestive system—esophageal cancer	0.00208	0.00449	CbGeAlD
Metformin—NDUFA9—digestive system—esophageal cancer	0.00208	0.00449	CbGeAlD
Metformin—NDUFA7—lung—esophageal cancer	0.00208	0.00448	CbGeAlD
Metformin—NDUFAF1—bronchus—esophageal cancer	0.00207	0.00448	CbGeAlD
Metformin—NDUFC1—smooth muscle tissue—esophageal cancer	0.00206	0.00446	CbGeAlD
Metformin—NDUFA1—digestive system—esophageal cancer	0.00205	0.00442	CbGeAlD
Metformin—NDUFB2—smooth muscle tissue—esophageal cancer	0.00205	0.00442	CbGeAlD
Metformin—NDUFB3—bronchus—esophageal cancer	0.00204	0.00441	CbGeAlD
Metformin—NDUFAF2—bronchus—esophageal cancer	0.00204	0.00441	CbGeAlD
Metformin—ND6—smooth muscle tissue—esophageal cancer	0.00201	0.00435	CbGeAlD
Metformin—Respiratory distress—Capecitabine—esophageal cancer	0.00201	0.0126	CcSEcCtD
Metformin—NDUFB3—smooth muscle tissue—esophageal cancer	0.002	0.00431	CbGeAlD
Metformin—NDUFA5—bronchus—esophageal cancer	0.00199	0.0043	CbGeAlD
Metformin—NDUFA11—bronchus—esophageal cancer	0.00199	0.0043	CbGeAlD
Metformin—NDUFV2—digestive system—esophageal cancer	0.00199	0.00429	CbGeAlD
Metformin—NDUFAF4—bronchus—esophageal cancer	0.00198	0.00427	CbGeAlD
Metformin—NDUFB6—bronchus—esophageal cancer	0.00198	0.00427	CbGeAlD
Metformin—Nail disorder—Capecitabine—esophageal cancer	0.00197	0.0123	CcSEcCtD
Metformin—NDUFA12—epithelium—esophageal cancer	0.00197	0.00424	CbGeAlD
Metformin—NDUFS1—bronchus—esophageal cancer	0.00196	0.00424	CbGeAlD
Metformin—NDUFB10—bronchus—esophageal cancer	0.00195	0.00421	CbGeAlD
Metformin—NDUFAF3—lung—esophageal cancer	0.00194	0.00419	CbGeAlD
Metformin—NDUFA12—bronchus—esophageal cancer	0.00194	0.00418	CbGeAlD
Metformin—NDUFB7—bronchus—esophageal cancer	0.00194	0.00418	CbGeAlD
Metformin—NDUFB6—smooth muscle tissue—esophageal cancer	0.00194	0.00418	CbGeAlD
Metformin—NDUFB1—bronchus—esophageal cancer	0.00192	0.00415	CbGeAlD
Metformin—NDUFS8—bronchus—esophageal cancer	0.00192	0.00415	CbGeAlD
Metformin—NDUFS1—smooth muscle tissue—esophageal cancer	0.00192	0.00415	CbGeAlD
Metformin—Appetite absent—Methotrexate—esophageal cancer	0.00191	0.0119	CcSEcCtD
Metformin—NDUFB5—bronchus—esophageal cancer	0.0019	0.0041	CbGeAlD
Metformin—NDUFA6—bronchus—esophageal cancer	0.0019	0.0041	CbGeAlD
Metformin—NDUFA12—smooth muscle tissue—esophageal cancer	0.00189	0.00409	CbGeAlD
Metformin—NDUFB7—smooth muscle tissue—esophageal cancer	0.00189	0.00409	CbGeAlD
Metformin—NDUFS4—bronchus—esophageal cancer	0.00188	0.00407	CbGeAlD
Metformin—NDUFB1—smooth muscle tissue—esophageal cancer	0.00188	0.00406	CbGeAlD
Metformin—NDUFS8—smooth muscle tissue—esophageal cancer	0.00188	0.00406	CbGeAlD
Metformin—NDUFAB1—epithelium—esophageal cancer	0.00188	0.00405	CbGeAlD
Metformin—NDUFB9—epithelium—esophageal cancer	0.00187	0.00403	CbGeAlD
Metformin—NDUFAF1—trachea—esophageal cancer	0.00186	0.00402	CbGeAlD
Metformin—NDUFB4—bronchus—esophageal cancer	0.00186	0.00402	CbGeAlD
Metformin—NDUFB5—smooth muscle tissue—esophageal cancer	0.00186	0.00401	CbGeAlD
Metformin—NDUFA6—smooth muscle tissue—esophageal cancer	0.00186	0.00401	CbGeAlD
Metformin—NDUFAB1—bronchus—esophageal cancer	0.00185	0.00399	CbGeAlD
Metformin—NDUFS4—smooth muscle tissue—esophageal cancer	0.00184	0.00398	CbGeAlD
Metformin—NDUFB9—bronchus—esophageal cancer	0.00184	0.00397	CbGeAlD
Metformin—NDUFA8—bronchus—esophageal cancer	0.00184	0.00397	CbGeAlD
Metformin—NDUFAF2—trachea—esophageal cancer	0.00183	0.00396	CbGeAlD
Metformin—NDUFB3—trachea—esophageal cancer	0.00183	0.00396	CbGeAlD
Metformin—NDUFS5—epithelium—esophageal cancer	0.00183	0.00396	CbGeAlD
Metformin—NDUFA4—bronchus—esophageal cancer	0.00183	0.00394	CbGeAlD
Metformin—NDUFB4—smooth muscle tissue—esophageal cancer	0.00182	0.00393	CbGeAlD
Metformin—ND3—digestive system—esophageal cancer	0.00182	0.00392	CbGeAlD
Metformin—ND5—digestive system—esophageal cancer	0.00182	0.00392	CbGeAlD
Metformin—ND2—digestive system—esophageal cancer	0.00182	0.00392	CbGeAlD
Metformin—ND4L—digestive system—esophageal cancer	0.00182	0.00392	CbGeAlD
Metformin—NDUFV1—bronchus—esophageal cancer	0.00182	0.00392	CbGeAlD
Metformin—NDUFB11—bronchus—esophageal cancer	0.00182	0.00392	CbGeAlD
Metformin—NDUFAB1—smooth muscle tissue—esophageal cancer	0.00181	0.0039	CbGeAlD
Metformin—NDUFS5—bronchus—esophageal cancer	0.0018	0.0039	CbGeAlD
Metformin—NDUFB8—bronchus—esophageal cancer	0.0018	0.0039	CbGeAlD
Metformin—NDUFA8—smooth muscle tissue—esophageal cancer	0.0018	0.00388	CbGeAlD
Metformin—NDUFB9—smooth muscle tissue—esophageal cancer	0.0018	0.00388	CbGeAlD
Metformin—NDUFA5—trachea—esophageal cancer	0.00179	0.00386	CbGeAlD
Metformin—NDUFA11—trachea—esophageal cancer	0.00179	0.00386	CbGeAlD
Metformin—NDUFA4—smooth muscle tissue—esophageal cancer	0.00179	0.00386	CbGeAlD
Metformin—Azotaemia—Methotrexate—esophageal cancer	0.00179	0.0112	CcSEcCtD
Metformin—NDUFB6—trachea—esophageal cancer	0.00178	0.00384	CbGeAlD
Metformin—NDUFAF4—trachea—esophageal cancer	0.00178	0.00384	CbGeAlD
Metformin—NDUFB11—smooth muscle tissue—esophageal cancer	0.00178	0.00383	CbGeAlD
Metformin—NDUFV1—smooth muscle tissue—esophageal cancer	0.00178	0.00383	CbGeAlD
Metformin—NDUFS5—smooth muscle tissue—esophageal cancer	0.00177	0.00381	CbGeAlD
Metformin—NDUFB8—smooth muscle tissue—esophageal cancer	0.00177	0.00381	CbGeAlD
Metformin—ND4—digestive system—esophageal cancer	0.00176	0.0038	CbGeAlD
Metformin—NDUFB10—trachea—esophageal cancer	0.00175	0.00378	CbGeAlD
Metformin—NDUFB7—trachea—esophageal cancer	0.00174	0.00375	CbGeAlD
Metformin—NDUFA12—trachea—esophageal cancer	0.00174	0.00375	CbGeAlD
Metformin—NDUFA9—lung—esophageal cancer	0.00174	0.00375	CbGeAlD
Metformin—NDUFA13—lung—esophageal cancer	0.00174	0.00375	CbGeAlD
Metformin—NDUFS8—trachea—esophageal cancer	0.00173	0.00373	CbGeAlD
Metformin—ND1—neck—esophageal cancer	0.00172	0.0037	CbGeAlD
Metformin—NDUFA1—lung—esophageal cancer	0.00171	0.00369	CbGeAlD
Metformin—NDUFA6—trachea—esophageal cancer	0.0017	0.00368	CbGeAlD
Metformin—NDUFB5—trachea—esophageal cancer	0.0017	0.00368	CbGeAlD
Metformin—NDUFS4—trachea—esophageal cancer	0.00169	0.00365	CbGeAlD
Metformin—NDUFS7—bronchus—esophageal cancer	0.00169	0.00365	CbGeAlD
Metformin—NDUFB4—trachea—esophageal cancer	0.00167	0.00361	CbGeAlD
Metformin—NDUFV2—lung—esophageal cancer	0.00166	0.00358	CbGeAlD
Metformin—NDUFAB1—trachea—esophageal cancer	0.00166	0.00358	CbGeAlD
Metformin—Fungal infection—Capecitabine—esophageal cancer	0.00166	0.0103	CcSEcCtD
Metformin—NDUFA8—trachea—esophageal cancer	0.00165	0.00356	CbGeAlD
Metformin—NDUFB9—trachea—esophageal cancer	0.00165	0.00356	CbGeAlD
Metformin—NDUFA10—digestive system—esophageal cancer	0.00164	0.00355	CbGeAlD
Metformin—NDUFA4—trachea—esophageal cancer	0.00164	0.00354	CbGeAlD
Metformin—NDUFB11—trachea—esophageal cancer	0.00163	0.00352	CbGeAlD
Metformin—NDUFV1—trachea—esophageal cancer	0.00163	0.00352	CbGeAlD
Metformin—Neuropathy—Cisplatin—esophageal cancer	0.00163	0.0102	CcSEcCtD
Metformin—NDUFS5—trachea—esophageal cancer	0.00162	0.0035	CbGeAlD
Metformin—NDUFB8—trachea—esophageal cancer	0.00162	0.0035	CbGeAlD
Metformin—NDUFB2—digestive system—esophageal cancer	0.00162	0.00349	CbGeAlD
Metformin—NDUFA4L2—lung—esophageal cancer	0.00162	0.00349	CbGeAlD
Metformin—ND6—digestive system—esophageal cancer	0.00159	0.00343	CbGeAlD
Metformin—Rhinorrhoea—Capecitabine—esophageal cancer	0.00158	0.00985	CcSEcCtD
Metformin—Rigors—Capecitabine—esophageal cancer	0.00157	0.00978	CcSEcCtD
Metformin—PRKAB1—bronchus—esophageal cancer	0.00155	0.00334	CbGeAlD
Metformin—NDUFA5—digestive system—esophageal cancer	0.00154	0.00332	CbGeAlD
Metformin—ND4L—lung—esophageal cancer	0.00152	0.00328	CbGeAlD
Metformin—ND5—lung—esophageal cancer	0.00152	0.00328	CbGeAlD
Metformin—ND3—lung—esophageal cancer	0.00152	0.00328	CbGeAlD
Metformin—ND2—lung—esophageal cancer	0.00152	0.00328	CbGeAlD
Metformin—NDUFS1—digestive system—esophageal cancer	0.00152	0.00328	CbGeAlD
Metformin—NDUFB10—digestive system—esophageal cancer	0.00151	0.00325	CbGeAlD
Metformin—NDUFB7—digestive system—esophageal cancer	0.0015	0.00323	CbGeAlD
Metformin—NDUFS8—digestive system—esophageal cancer	0.00149	0.00321	CbGeAlD
Metformin—NDUFB1—digestive system—esophageal cancer	0.00149	0.00321	CbGeAlD
Metformin—NDUFC2—epithelium—esophageal cancer	0.00148	0.00319	CbGeAlD
Metformin—ND4—lung—esophageal cancer	0.00147	0.00317	CbGeAlD
Metformin—Nail disorder—Methotrexate—esophageal cancer	0.00147	0.00916	CcSEcCtD
Metformin—NDUFA6—digestive system—esophageal cancer	0.00147	0.00316	CbGeAlD
Metformin—NDUFB5—digestive system—esophageal cancer	0.00147	0.00316	CbGeAlD
Metformin—Contusion—Capecitabine—esophageal cancer	0.00147	0.00915	CcSEcCtD
Metformin—NDUFC2—bronchus—esophageal cancer	0.00146	0.00315	CbGeAlD
Metformin—NDUFS4—digestive system—esophageal cancer	0.00146	0.00314	CbGeAlD
Metformin—Chest discomfort—Capecitabine—esophageal cancer	0.00144	0.00902	CcSEcCtD
Metformin—NDUFA2—lung—esophageal cancer	0.00144	0.00311	CbGeAlD
Metformin—NDUFB4—digestive system—esophageal cancer	0.00144	0.0031	CbGeAlD
Metformin—NDUFAB1—digestive system—esophageal cancer	0.00143	0.00308	CbGeAlD
Metformin—NDUFA7—lymph node—esophageal cancer	0.00142	0.00307	CbGeAlD
Metformin—NDUFB9—digestive system—esophageal cancer	0.00142	0.00306	CbGeAlD
Metformin—NDUFA8—digestive system—esophageal cancer	0.00142	0.00306	CbGeAlD
Metformin—NDUFA4—digestive system—esophageal cancer	0.00141	0.00305	CbGeAlD
Metformin—NDUFV1—digestive system—esophageal cancer	0.0014	0.00303	CbGeAlD
Metformin—NDUFB11—digestive system—esophageal cancer	0.0014	0.00303	CbGeAlD
Metformin—NDUFS2—bronchus—esophageal cancer	0.0014	0.00302	CbGeAlD
Metformin—NDUFB8—digestive system—esophageal cancer	0.00139	0.00301	CbGeAlD
Metformin—NDUFS5—digestive system—esophageal cancer	0.00139	0.00301	CbGeAlD
Metformin—PRKAB1—trachea—esophageal cancer	0.00139	0.003	CbGeAlD
Metformin—NDUFS3—bronchus—esophageal cancer	0.00138	0.00299	CbGeAlD
Metformin—Nasal congestion—Cisplatin—esophageal cancer	0.00138	0.00863	CcSEcCtD
Metformin—NDUFA10—lung—esophageal cancer	0.00137	0.00296	CbGeAlD
Metformin—NDUFS2—smooth muscle tissue—esophageal cancer	0.00137	0.00296	CbGeAlD
Metformin—NDUFC1—lung—esophageal cancer	0.00136	0.00294	CbGeAlD
Metformin—NDUFS3—smooth muscle tissue—esophageal cancer	0.00135	0.00292	CbGeAlD
Metformin—NDUFB2—lung—esophageal cancer	0.00135	0.00291	CbGeAlD
Metformin—NDUFAF1—lung—esophageal cancer	0.00134	0.00289	CbGeAlD
Metformin—ND6—lung—esophageal cancer	0.00133	0.00287	CbGeAlD
Metformin—NDUFB3—lung—esophageal cancer	0.00132	0.00284	CbGeAlD
Metformin—NDUFAF2—lung—esophageal cancer	0.00132	0.00284	CbGeAlD
Metformin—NDUFC2—trachea—esophageal cancer	0.00131	0.00282	CbGeAlD
Metformin—NDUFS7—digestive system—esophageal cancer	0.00131	0.00282	CbGeAlD
Metformin—NDUFA11—lung—esophageal cancer	0.00129	0.00278	CbGeAlD
Metformin—NDUFA5—lung—esophageal cancer	0.00129	0.00278	CbGeAlD
Metformin—NDUFB6—lung—esophageal cancer	0.00128	0.00276	CbGeAlD
Metformin—NDUFAF4—lung—esophageal cancer	0.00128	0.00276	CbGeAlD
Metformin—NDUFS1—lung—esophageal cancer	0.00127	0.00274	CbGeAlD
Metformin—NDUFB10—lung—esophageal cancer	0.00126	0.00272	CbGeAlD
Metformin—NDUFS2—trachea—esophageal cancer	0.00126	0.00272	CbGeAlD
Metformin—NDUFB7—lung—esophageal cancer	0.00125	0.0027	CbGeAlD
Metformin—NDUFA12—lung—esophageal cancer	0.00125	0.0027	CbGeAlD
Metformin—NDUFS3—trachea—esophageal cancer	0.00124	0.00268	CbGeAlD
Metformin—NDUFS8—lung—esophageal cancer	0.00124	0.00268	CbGeAlD
Metformin—NDUFB1—lung—esophageal cancer	0.00124	0.00268	CbGeAlD
Metformin—Fungal infection—Methotrexate—esophageal cancer	0.00123	0.0077	CcSEcCtD
Metformin—NDUFB5—lung—esophageal cancer	0.00122	0.00264	CbGeAlD
Metformin—NDUFA6—lung—esophageal cancer	0.00122	0.00264	CbGeAlD
Metformin—NDUFS4—lung—esophageal cancer	0.00122	0.00262	CbGeAlD
Metformin—NDUFB4—lung—esophageal cancer	0.0012	0.00259	CbGeAlD
Metformin—Neuropathy—Capecitabine—esophageal cancer	0.0012	0.0075	CcSEcCtD
Metformin—PRKAB1—digestive system—esophageal cancer	0.00119	0.00258	CbGeAlD
Metformin—NDUFAB1—lung—esophageal cancer	0.00119	0.00257	CbGeAlD
Metformin—NDUFA8—lung—esophageal cancer	0.00119	0.00256	CbGeAlD
Metformin—NDUFB9—lung—esophageal cancer	0.00119	0.00256	CbGeAlD
Metformin—NDUFA4—lung—esophageal cancer	0.00118	0.00254	CbGeAlD
Metformin—NDUFV1—lung—esophageal cancer	0.00117	0.00253	CbGeAlD
Metformin—NDUFB11—lung—esophageal cancer	0.00117	0.00253	CbGeAlD
Metformin—Dehydration—Cisplatin—esophageal cancer	0.00117	0.00731	CcSEcCtD
Metformin—NDUFB8—lung—esophageal cancer	0.00116	0.00251	CbGeAlD
Metformin—NDUFS5—lung—esophageal cancer	0.00116	0.00251	CbGeAlD
Metformin—Breast disorder—Cisplatin—esophageal cancer	0.00114	0.0071	CcSEcCtD
Metformin—NDUFV2—lymph node—esophageal cancer	0.00114	0.00245	CbGeAlD
Metformin—Cramp muscle—Cisplatin—esophageal cancer	0.00113	0.00708	CcSEcCtD
Metformin—NDUFC2—digestive system—esophageal cancer	0.00113	0.00243	CbGeAlD
Metformin—Nasopharyngitis—Cisplatin—esophageal cancer	0.00113	0.00703	CcSEcCtD
Metformin—ND1—smooth muscle tissue—esophageal cancer	0.00112	0.00243	CbGeAlD
Metformin—NDUFA4L2—lymph node—esophageal cancer	0.0011	0.00238	CbGeAlD
Metformin—NDUFS7—lung—esophageal cancer	0.00109	0.00236	CbGeAlD
Metformin—Ear pain—Capecitabine—esophageal cancer	0.00109	0.00679	CcSEcCtD
Metformin—NDUFS2—digestive system—esophageal cancer	0.00108	0.00234	CbGeAlD
Metformin—NDUFS3—digestive system—esophageal cancer	0.00107	0.00231	CbGeAlD
Metformin—Pancreatitis—Cisplatin—esophageal cancer	0.00107	0.00666	CcSEcCtD
Metformin—Sweating increased—Cisplatin—esophageal cancer	0.00106	0.00662	CcSEcCtD
Metformin—Abdominal discomfort—Cisplatin—esophageal cancer	0.00104	0.00651	CcSEcCtD
Metformin—ND4L—lymph node—esophageal cancer	0.00104	0.00224	CbGeAlD
Metformin—ND5—lymph node—esophageal cancer	0.00104	0.00224	CbGeAlD
Metformin—ND2—lymph node—esophageal cancer	0.00104	0.00224	CbGeAlD
Metformin—ND3—lymph node—esophageal cancer	0.00104	0.00224	CbGeAlD
Metformin—ND4—lymph node—esophageal cancer	0.00101	0.00217	CbGeAlD
Metformin—PRKAB1—lung—esophageal cancer	0.000998	0.00215	CbGeAlD
Metformin—NDUFA2—lymph node—esophageal cancer	0.000985	0.00213	CbGeAlD
Metformin—Renal impairment—Capecitabine—esophageal cancer	0.000975	0.00609	CcSEcCtD
Metformin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000951	0.00594	CcSEcCtD
Metformin—Lethargy—Capecitabine—esophageal cancer	0.000947	0.00591	CcSEcCtD
Metformin—NDUFC2—lung—esophageal cancer	0.00094	0.00203	CbGeAlD
Metformin—NDUFA10—lymph node—esophageal cancer	0.000939	0.00203	CbGeAlD
Metformin—NDUFC1—lymph node—esophageal cancer	0.000931	0.00201	CbGeAlD
Metformin—Pain in extremity—Capecitabine—esophageal cancer	0.000928	0.0058	CcSEcCtD
Metformin—NDUFB2—lymph node—esophageal cancer	0.000923	0.00199	CbGeAlD
Metformin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000917	0.00573	CcSEcCtD
Metformin—NDUFAF1—lymph node—esophageal cancer	0.000915	0.00198	CbGeAlD
Metformin—Migraine—Capecitabine—esophageal cancer	0.000913	0.0057	CcSEcCtD
Metformin—ND6—lymph node—esophageal cancer	0.000908	0.00196	CbGeAlD
Metformin—NDUFS2—lung—esophageal cancer	0.000904	0.00195	CbGeAlD
Metformin—NDUFAF2—lymph node—esophageal cancer	0.000901	0.00194	CbGeAlD
Metformin—NDUFB3—lymph node—esophageal cancer	0.000901	0.00194	CbGeAlD
Metformin—NDUFS3—lung—esophageal cancer	0.000893	0.00193	CbGeAlD
Metformin—ND1—digestive system—esophageal cancer	0.000888	0.00192	CbGeAlD
Metformin—Bradycardia—Cisplatin—esophageal cancer	0.000887	0.00554	CcSEcCtD
Metformin—NDUFA5—lymph node—esophageal cancer	0.00088	0.0019	CbGeAlD
Metformin—NDUFA11—lymph node—esophageal cancer	0.00088	0.0019	CbGeAlD
Metformin—NDUFAF4—lymph node—esophageal cancer	0.000873	0.00188	CbGeAlD
Metformin—NDUFB6—lymph node—esophageal cancer	0.000873	0.00188	CbGeAlD
Metformin—NDUFS1—lymph node—esophageal cancer	0.000867	0.00187	CbGeAlD
Metformin—Dehydration—Capecitabine—esophageal cancer	0.000863	0.00539	CcSEcCtD
Metformin—NDUFB10—lymph node—esophageal cancer	0.000861	0.00186	CbGeAlD
Metformin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000857	0.00535	CcSEcCtD
Metformin—Connective tissue disorder—Cisplatin—esophageal cancer	0.000856	0.00534	CcSEcCtD
Metformin—NDUFA12—lymph node—esophageal cancer	0.000855	0.00184	CbGeAlD
Metformin—NDUFB7—lymph node—esophageal cancer	0.000855	0.00184	CbGeAlD
Metformin—NDUFB1—lymph node—esophageal cancer	0.000849	0.00183	CbGeAlD
Metformin—NDUFS8—lymph node—esophageal cancer	0.000849	0.00183	CbGeAlD
Metformin—Abdominal pain upper—Capecitabine—esophageal cancer	0.000848	0.00529	CcSEcCtD
Metformin—Breast disorder—Capecitabine—esophageal cancer	0.000839	0.00524	CcSEcCtD
Metformin—NDUFB5—lymph node—esophageal cancer	0.000837	0.00181	CbGeAlD
Metformin—NDUFA6—lymph node—esophageal cancer	0.000837	0.00181	CbGeAlD
Metformin—NDUFS4—lymph node—esophageal cancer	0.000832	0.0018	CbGeAlD
Metformin—Nasopharyngitis—Capecitabine—esophageal cancer	0.00083	0.00518	CcSEcCtD
Metformin—NDUFB4—lymph node—esophageal cancer	0.000821	0.00177	CbGeAlD
Metformin—NDUFAB1—lymph node—esophageal cancer	0.000816	0.00176	CbGeAlD
Metformin—Eye disorder—Cisplatin—esophageal cancer	0.000814	0.00508	CcSEcCtD
Metformin—NDUFB9—lymph node—esophageal cancer	0.000811	0.00175	CbGeAlD
Metformin—NDUFA8—lymph node—esophageal cancer	0.000811	0.00175	CbGeAlD
Metformin—Flushing—Cisplatin—esophageal cancer	0.000808	0.00505	CcSEcCtD
Metformin—Cardiac disorder—Cisplatin—esophageal cancer	0.000808	0.00505	CcSEcCtD
Metformin—Abdominal distension—Capecitabine—esophageal cancer	0.000807	0.00504	CcSEcCtD
Metformin—NDUFA4—lymph node—esophageal cancer	0.000806	0.00174	CbGeAlD
Metformin—Influenza—Capecitabine—esophageal cancer	0.000802	0.00501	CcSEcCtD
Metformin—NDUFB11—lymph node—esophageal cancer	0.000801	0.00173	CbGeAlD
Metformin—NDUFV1—lymph node—esophageal cancer	0.000801	0.00173	CbGeAlD
Metformin—NDUFB8—lymph node—esophageal cancer	0.000796	0.00172	CbGeAlD
Metformin—NDUFS5—lymph node—esophageal cancer	0.000796	0.00172	CbGeAlD
Metformin—Immune system disorder—Cisplatin—esophageal cancer	0.000787	0.00491	CcSEcCtD
Metformin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000785	0.0049	CcSEcCtD
Metformin—Sweating increased—Capecitabine—esophageal cancer	0.000781	0.00488	CcSEcCtD
Metformin—Angina pectoris—Capecitabine—esophageal cancer	0.000781	0.00488	CcSEcCtD
Metformin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000769	0.0048	CcSEcCtD
Metformin—Malnutrition—Cisplatin—esophageal cancer	0.000758	0.00473	CcSEcCtD
Metformin—Erythema—Cisplatin—esophageal cancer	0.000758	0.00473	CcSEcCtD
Metformin—Neutropenia—Capecitabine—esophageal cancer	0.00075	0.00468	CcSEcCtD
Metformin—Flatulence—Cisplatin—esophageal cancer	0.000747	0.00467	CcSEcCtD
Metformin—NDUFS7—lymph node—esophageal cancer	0.000746	0.00161	CbGeAlD
Metformin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000745	0.00466	CcSEcCtD
Metformin—ND1—lung—esophageal cancer	0.000742	0.0016	CbGeAlD
Metformin—Muscle spasms—Cisplatin—esophageal cancer	0.000729	0.00455	CcSEcCtD
Metformin—Infestation NOS—Capecitabine—esophageal cancer	0.000715	0.00447	CcSEcCtD
Metformin—Infestation—Capecitabine—esophageal cancer	0.000715	0.00447	CcSEcCtD
Metformin—Vision blurred—Cisplatin—esophageal cancer	0.000714	0.00446	CcSEcCtD
Metformin—SLC22A2—digestive system—esophageal cancer	0.000713	0.00154	CbGeAlD
Metformin—Tremor—Cisplatin—esophageal cancer	0.00071	0.00444	CcSEcCtD
Metformin—Lethargy—Methotrexate—esophageal cancer	0.000705	0.0044	CcSEcCtD
Metformin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000703	0.00439	CcSEcCtD
Metformin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000701	0.00438	CcSEcCtD
Metformin—Malaise—Cisplatin—esophageal cancer	0.000684	0.00427	CcSEcCtD
Metformin—PRKAB1—lymph node—esophageal cancer	0.000682	0.00147	CbGeAlD
Metformin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000676	0.00422	CcSEcCtD
Metformin—Bradycardia—Capecitabine—esophageal cancer	0.000654	0.00408	CcSEcCtD
Metformin—Myalgia—Cisplatin—esophageal cancer	0.000645	0.00403	CcSEcCtD
Metformin—Rhinitis—Capecitabine—esophageal cancer	0.000644	0.00402	CcSEcCtD
Metformin—NDUFC2—lymph node—esophageal cancer	0.000643	0.00139	CbGeAlD
Metformin—Hepatitis—Capecitabine—esophageal cancer	0.000642	0.00401	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000641	0.004	CcSEcCtD
Metformin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000639	0.00399	CcSEcCtD
Metformin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000638	0.00398	CcSEcCtD
Metformin—Discomfort—Cisplatin—esophageal cancer	0.000638	0.00398	CcSEcCtD
Metformin—Oedema peripheral—Capecitabine—esophageal cancer	0.000632	0.00395	CcSEcCtD
Metformin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000631	0.00394	CcSEcCtD
Metformin—Breast disorder—Methotrexate—esophageal cancer	0.000624	0.0039	CcSEcCtD
Metformin—Oedema—Cisplatin—esophageal cancer	0.000619	0.00386	CcSEcCtD
Metformin—NDUFS2—lymph node—esophageal cancer	0.000618	0.00133	CbGeAlD
Metformin—Infection—Cisplatin—esophageal cancer	0.000615	0.00384	CcSEcCtD
Metformin—NDUFS3—lymph node—esophageal cancer	0.000611	0.00132	CbGeAlD
Metformin—SLC22A3—smooth muscle tissue—esophageal cancer	0.000609	0.00132	CbGeAlD
Metformin—Nervous system disorder—Cisplatin—esophageal cancer	0.000607	0.00379	CcSEcCtD
Metformin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000606	0.00378	CcSEcCtD
Metformin—SLC47A1—digestive system—esophageal cancer	0.000603	0.0013	CbGeAlD
Metformin—Skin disorder—Cisplatin—esophageal cancer	0.000601	0.00375	CcSEcCtD
Metformin—Eye disorder—Capecitabine—esophageal cancer	0.0006	0.00375	CcSEcCtD
Metformin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000598	0.00374	CcSEcCtD
Metformin—Cardiac disorder—Capecitabine—esophageal cancer	0.000596	0.00372	CcSEcCtD
Metformin—Flushing—Capecitabine—esophageal cancer	0.000596	0.00372	CcSEcCtD
Metformin—Anorexia—Cisplatin—esophageal cancer	0.00059	0.00368	CcSEcCtD
Metformin—Pancreatitis—Methotrexate—esophageal cancer	0.000585	0.00366	CcSEcCtD
Metformin—Angiopathy—Capecitabine—esophageal cancer	0.000582	0.00364	CcSEcCtD
Metformin—Immune system disorder—Capecitabine—esophageal cancer	0.00058	0.00362	CcSEcCtD
Metformin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000579	0.00361	CcSEcCtD
Metformin—Hypotension—Cisplatin—esophageal cancer	0.000578	0.00361	CcSEcCtD
Metformin—Chills—Capecitabine—esophageal cancer	0.000576	0.0036	CcSEcCtD
Metformin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000572	0.00357	CcSEcCtD
Metformin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000564	0.00352	CcSEcCtD
Metformin—Erythema—Capecitabine—esophageal cancer	0.000559	0.00349	CcSEcCtD
Metformin—Malnutrition—Capecitabine—esophageal cancer	0.000559	0.00349	CcSEcCtD
Metformin—Neutropenia—Methotrexate—esophageal cancer	0.000558	0.00349	CcSEcCtD
Metformin—Paraesthesia—Cisplatin—esophageal cancer	0.000556	0.00347	CcSEcCtD
Metformin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000555	0.00347	CcSEcCtD
Metformin—Dyspnoea—Cisplatin—esophageal cancer	0.000552	0.00344	CcSEcCtD
Metformin—Flatulence—Capecitabine—esophageal cancer	0.000551	0.00344	CcSEcCtD
Metformin—Dysgeusia—Capecitabine—esophageal cancer	0.000547	0.00342	CcSEcCtD
Metformin—Decreased appetite—Cisplatin—esophageal cancer	0.000538	0.00336	CcSEcCtD
Metformin—Muscle spasms—Capecitabine—esophageal cancer	0.000537	0.00336	CcSEcCtD
Metformin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000534	0.00334	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—esophageal cancer	0.000532	0.00332	CcSEcCtD
Metformin—Drowsiness—Methotrexate—esophageal cancer	0.000532	0.00332	CcSEcCtD
Metformin—Infestation—Methotrexate—esophageal cancer	0.000532	0.00332	CcSEcCtD
Metformin—Vision blurred—Capecitabine—esophageal cancer	0.000527	0.00329	CcSEcCtD
Metformin—Tremor—Capecitabine—esophageal cancer	0.000524	0.00327	CcSEcCtD
Metformin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000518	0.00324	CcSEcCtD
Metformin—Feeling abnormal—Cisplatin—esophageal cancer	0.00051	0.00318	CcSEcCtD
Metformin—ND1—lymph node—esophageal cancer	0.000507	0.00109	CbGeAlD
Metformin—Malaise—Capecitabine—esophageal cancer	0.000504	0.00315	CcSEcCtD
Metformin—SLC47A1—lung—esophageal cancer	0.000504	0.00109	CbGeAlD
Metformin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000503	0.00314	CcSEcCtD
Metformin—Syncope—Capecitabine—esophageal cancer	0.000501	0.00313	CcSEcCtD
Metformin—Palpitations—Capecitabine—esophageal cancer	0.000494	0.00308	CcSEcCtD
Metformin—Loss of consciousness—Capecitabine—esophageal cancer	0.000491	0.00307	CcSEcCtD
Metformin—Hypertension—Capecitabine—esophageal cancer	0.000482	0.00301	CcSEcCtD
Metformin—Hepatitis—Methotrexate—esophageal cancer	0.000478	0.00298	CcSEcCtD
Metformin—Myalgia—Capecitabine—esophageal cancer	0.000476	0.00297	CcSEcCtD
Metformin—Chest pain—Capecitabine—esophageal cancer	0.000476	0.00297	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000472	0.00295	CcSEcCtD
Metformin—Discomfort—Capecitabine—esophageal cancer	0.00047	0.00294	CcSEcCtD
Metformin—Oedema—Capecitabine—esophageal cancer	0.000456	0.00285	CcSEcCtD
Metformin—Infection—Capecitabine—esophageal cancer	0.000453	0.00283	CcSEcCtD
Metformin—Shock—Capecitabine—esophageal cancer	0.000449	0.0028	CcSEcCtD
Metformin—Nervous system disorder—Capecitabine—esophageal cancer	0.000447	0.00279	CcSEcCtD
Metformin—Eye disorder—Methotrexate—esophageal cancer	0.000447	0.00279	CcSEcCtD
Metformin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000447	0.00279	CcSEcCtD
Metformin—Asthenia—Cisplatin—esophageal cancer	0.000444	0.00277	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—esophageal cancer	0.000444	0.00277	CcSEcCtD
Metformin—Skin disorder—Capecitabine—esophageal cancer	0.000443	0.00277	CcSEcCtD
Metformin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000441	0.00275	CcSEcCtD
Metformin—Anorexia—Capecitabine—esophageal cancer	0.000435	0.00272	CcSEcCtD
Metformin—Angiopathy—Methotrexate—esophageal cancer	0.000434	0.00271	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—esophageal cancer	0.000432	0.0027	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000431	0.00269	CcSEcCtD
Metformin—Chills—Methotrexate—esophageal cancer	0.000429	0.00268	CcSEcCtD
Metformin—Hypotension—Capecitabine—esophageal cancer	0.000426	0.00266	CcSEcCtD
Metformin—Diarrhoea—Cisplatin—esophageal cancer	0.000423	0.00264	CcSEcCtD
Metformin—Erythema—Methotrexate—esophageal cancer	0.000416	0.0026	CcSEcCtD
Metformin—Malnutrition—Methotrexate—esophageal cancer	0.000416	0.0026	CcSEcCtD
Metformin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000416	0.0026	CcSEcCtD
Metformin—Paraesthesia—Capecitabine—esophageal cancer	0.00041	0.00256	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—esophageal cancer	0.000407	0.00254	CcSEcCtD
Metformin—Dyspnoea—Capecitabine—esophageal cancer	0.000407	0.00254	CcSEcCtD
Metformin—SLC22A3—lung—esophageal cancer	0.000402	0.000867	CbGeAlD
Metformin—Dyspepsia—Capecitabine—esophageal cancer	0.000401	0.00251	CcSEcCtD
Metformin—Decreased appetite—Capecitabine—esophageal cancer	0.000396	0.00248	CcSEcCtD
Metformin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000394	0.00246	CcSEcCtD
Metformin—Vomiting—Cisplatin—esophageal cancer	0.000393	0.00246	CcSEcCtD
Metformin—Fatigue—Capecitabine—esophageal cancer	0.000393	0.00246	CcSEcCtD
Metformin—Vision blurred—Methotrexate—esophageal cancer	0.000392	0.00245	CcSEcCtD
Metformin—Rash—Cisplatin—esophageal cancer	0.00039	0.00244	CcSEcCtD
Metformin—Constipation—Capecitabine—esophageal cancer	0.00039	0.00244	CcSEcCtD
Metformin—Dermatitis—Cisplatin—esophageal cancer	0.00039	0.00243	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000386	0.00241	CcSEcCtD
Metformin—Feeling abnormal—Capecitabine—esophageal cancer	0.000376	0.00235	CcSEcCtD
Metformin—Malaise—Methotrexate—esophageal cancer	0.000375	0.00234	CcSEcCtD
Metformin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000373	0.00233	CcSEcCtD
Metformin—Nausea—Cisplatin—esophageal cancer	0.000368	0.0023	CcSEcCtD
Metformin—Urticaria—Capecitabine—esophageal cancer	0.000362	0.00226	CcSEcCtD
Metformin—Abdominal pain—Capecitabine—esophageal cancer	0.000361	0.00225	CcSEcCtD
Metformin—Myalgia—Methotrexate—esophageal cancer	0.000354	0.00221	CcSEcCtD
Metformin—Chest pain—Methotrexate—esophageal cancer	0.000354	0.00221	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000352	0.0022	CcSEcCtD
Metformin—Discomfort—Methotrexate—esophageal cancer	0.00035	0.00219	CcSEcCtD
Metformin—SLC47A1—lymph node—esophageal cancer	0.000345	0.000744	CbGeAlD
Metformin—Infection—Methotrexate—esophageal cancer	0.000337	0.00211	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—esophageal cancer	0.000333	0.00208	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000332	0.00208	CcSEcCtD
Metformin—Skin disorder—Methotrexate—esophageal cancer	0.00033	0.00206	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000328	0.00205	CcSEcCtD
Metformin—Asthenia—Capecitabine—esophageal cancer	0.000327	0.00204	CcSEcCtD
Metformin—Anorexia—Methotrexate—esophageal cancer	0.000324	0.00202	CcSEcCtD
Metformin—Pruritus—Capecitabine—esophageal cancer	0.000323	0.00202	CcSEcCtD
Metformin—Hypotension—Methotrexate—esophageal cancer	0.000317	0.00198	CcSEcCtD
Metformin—Diarrhoea—Capecitabine—esophageal cancer	0.000312	0.00195	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000309	0.00193	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—esophageal cancer	0.000305	0.0019	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—esophageal cancer	0.000303	0.00189	CcSEcCtD
Metformin—Somnolence—Methotrexate—esophageal cancer	0.000302	0.00189	CcSEcCtD
Metformin—Dizziness—Capecitabine—esophageal cancer	0.000302	0.00188	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—esophageal cancer	0.000299	0.00187	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—esophageal cancer	0.000295	0.00184	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000293	0.00183	CcSEcCtD
Metformin—Fatigue—Methotrexate—esophageal cancer	0.000293	0.00183	CcSEcCtD
Metformin—Vomiting—Capecitabine—esophageal cancer	0.00029	0.00181	CcSEcCtD
Metformin—Rash—Capecitabine—esophageal cancer	0.000288	0.0018	CcSEcCtD
Metformin—Dermatitis—Capecitabine—esophageal cancer	0.000287	0.00179	CcSEcCtD
Metformin—Headache—Capecitabine—esophageal cancer	0.000286	0.00178	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—esophageal cancer	0.00028	0.00175	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000278	0.00173	CcSEcCtD
Metformin—SLC22A3—lymph node—esophageal cancer	0.000275	0.000593	CbGeAlD
Metformin—Nausea—Capecitabine—esophageal cancer	0.000271	0.00169	CcSEcCtD
Metformin—Urticaria—Methotrexate—esophageal cancer	0.00027	0.00168	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—esophageal cancer	0.000268	0.00168	CcSEcCtD
Metformin—Asthenia—Methotrexate—esophageal cancer	0.000244	0.00152	CcSEcCtD
Metformin—Pruritus—Methotrexate—esophageal cancer	0.00024	0.0015	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—esophageal cancer	0.000232	0.00145	CcSEcCtD
Metformin—Dizziness—Methotrexate—esophageal cancer	0.000225	0.0014	CcSEcCtD
Metformin—Vomiting—Methotrexate—esophageal cancer	0.000216	0.00135	CcSEcCtD
Metformin—Rash—Methotrexate—esophageal cancer	0.000214	0.00134	CcSEcCtD
Metformin—Dermatitis—Methotrexate—esophageal cancer	0.000214	0.00134	CcSEcCtD
Metformin—Headache—Methotrexate—esophageal cancer	0.000213	0.00133	CcSEcCtD
Metformin—Nausea—Methotrexate—esophageal cancer	0.000202	0.00126	CcSEcCtD
Metformin—NDUFA7—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—ND6—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—ND5—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—ND2—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTGS2—esophageal cancer	5.11e-05	0.000136	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—EP300—esophageal cancer	5e-05	0.000133	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5e-05	0.000133	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—NOS3—esophageal cancer	4.98e-05	0.000132	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PSME1—esophageal cancer	4.95e-05	0.000131	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PSME2—esophageal cancer	4.95e-05	0.000131	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ANXA1—esophageal cancer	4.93e-05	0.000131	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.86e-05	0.000129	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ADH1B—esophageal cancer	4.83e-05	0.000128	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SST—esophageal cancer	4.79e-05	0.000127	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BLVRB—esophageal cancer	4.78e-05	0.000127	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC52A3—esophageal cancer	4.78e-05	0.000127	CbGpPWpGaD
Metformin—ND1—Metabolism—HMOX1—esophageal cancer	4.75e-05	0.000126	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—CREBBP—esophageal cancer	4.73e-05	0.000126	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CREBBP—esophageal cancer	4.73e-05	0.000126	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CREBBP—esophageal cancer	4.73e-05	0.000126	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.72e-05	0.000125	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GHRL—esophageal cancer	4.67e-05	0.000124	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH3—esophageal cancer	4.67e-05	0.000124	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMP—esophageal cancer	4.62e-05	0.000123	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FBXW7—esophageal cancer	4.59e-05	0.000122	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—EP300—esophageal cancer	4.57e-05	0.000121	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—EP300—esophageal cancer	4.57e-05	0.000121	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—EP300—esophageal cancer	4.57e-05	0.000121	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—EP300—esophageal cancer	4.57e-05	0.000121	CbGpPWpGaD
Metformin—ND1—Metabolism—ABCB1—esophageal cancer	4.56e-05	0.000121	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—esophageal cancer	4.55e-05	0.000121	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.53e-05	0.00012	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.53e-05	0.00012	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP26A1—esophageal cancer	4.49e-05	0.000119	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BLVRB—esophageal cancer	4.45e-05	0.000118	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC52A3—esophageal cancer	4.45e-05	0.000118	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—CREBBP—esophageal cancer	4.45e-05	0.000118	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALOX15—esophageal cancer	4.38e-05	0.000116	CbGpPWpGaD
Metformin—ND6—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—ND5—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—ND3—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—ND4L—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—ND2—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—ND4—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—EP300—esophageal cancer	4.25e-05	0.000113	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—NOS3—esophageal cancer	4.23e-05	0.000112	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—NOS3—esophageal cancer	4.23e-05	0.000112	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—NOS3—esophageal cancer	4.23e-05	0.000112	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH2—esophageal cancer	4.19e-05	0.000111	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTO1—esophageal cancer	4.17e-05	0.000111	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TPI1—esophageal cancer	4.17e-05	0.000111	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CA1—esophageal cancer	4.06e-05	0.000108	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC10A2—esophageal cancer	4.06e-05	0.000108	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALDOB—esophageal cancer	4e-05	0.000106	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—NOS3—esophageal cancer	3.98e-05	0.000106	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—esophageal cancer	3.87e-05	0.000103	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—esophageal cancer	3.87e-05	0.000103	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—esophageal cancer	3.87e-05	0.000103	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GAPDH—esophageal cancer	3.85e-05	0.000102	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CRABP1—esophageal cancer	3.82e-05	0.000101	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—EP300—esophageal cancer	3.79e-05	0.000101	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CA1—esophageal cancer	3.79e-05	0.000101	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC10A2—esophageal cancer	3.79e-05	0.000101	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFBR2—esophageal cancer	3.72e-05	9.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CA2—esophageal cancer	3.72e-05	9.87e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—esophageal cancer	3.7e-05	9.81e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—esophageal cancer	3.64e-05	9.67e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GNG7—esophageal cancer	3.63e-05	9.64e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SMAD4—esophageal cancer	3.52e-05	9.34e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CA2—esophageal cancer	3.46e-05	9.2e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADH7—esophageal cancer	3.45e-05	9.17e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PLCE1—esophageal cancer	3.45e-05	9.17e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALDH2—esophageal cancer	3.4e-05	9.04e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—esophageal cancer	3.38e-05	8.98e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—esophageal cancer	3.38e-05	8.98e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—esophageal cancer	3.38e-05	8.98e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—esophageal cancer	3.38e-05	8.98e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTT1—esophageal cancer	3.24e-05	8.59e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—EP300—esophageal cancer	3.22e-05	8.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADH7—esophageal cancer	3.22e-05	8.55e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—EP300—esophageal cancer	3.22e-05	8.55e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—EP300—esophageal cancer	3.22e-05	8.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PLCE1—esophageal cancer	3.22e-05	8.55e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2A6—esophageal cancer	3.2e-05	8.5e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—esophageal cancer	3.14e-05	8.35e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CREBBP—esophageal cancer	3.05e-05	8.09e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ENO1—esophageal cancer	3.03e-05	8.05e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS1—esophageal cancer	3.03e-05	8.05e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.03e-05	8.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADH1B—esophageal cancer	3.03e-05	8.04e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—EP300—esophageal cancer	3.03e-05	8.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PSME2—esophageal cancer	2.99e-05	7.94e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PSME1—esophageal cancer	2.99e-05	7.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.96e-05	7.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMP—esophageal cancer	2.89e-05	7.69e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—esophageal cancer	2.88e-05	7.64e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.84e-05	7.55e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADH1B—esophageal cancer	2.82e-05	7.5e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP26A1—esophageal cancer	2.82e-05	7.48e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—esophageal cancer	2.8e-05	7.44e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.76e-05	7.33e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—esophageal cancer	2.75e-05	7.31e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALOX15—esophageal cancer	2.74e-05	7.29e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—NOS3—esophageal cancer	2.73e-05	7.24e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMP—esophageal cancer	2.7e-05	7.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.65e-05	7.04e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP26A1—esophageal cancer	2.62e-05	6.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTO1—esophageal cancer	2.62e-05	6.95e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TPI1—esophageal cancer	2.62e-05	6.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOTCH1—esophageal cancer	2.59e-05	6.88e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1B1—esophageal cancer	2.58e-05	6.85e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALOX15—esophageal cancer	2.56e-05	6.79e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDOB—esophageal cancer	2.51e-05	6.66e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—esophageal cancer	2.49e-05	6.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTO1—esophageal cancer	2.44e-05	6.48e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TPI1—esophageal cancer	2.44e-05	6.48e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP19A1—esophageal cancer	2.42e-05	6.44e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GAPDH—esophageal cancer	2.42e-05	6.42e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CRABP1—esophageal cancer	2.39e-05	6.36e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—esophageal cancer	2.38e-05	6.32e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—esophageal cancer	2.38e-05	6.32e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—esophageal cancer	2.38e-05	6.32e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CREBBP—esophageal cancer	2.35e-05	6.24e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDOB—esophageal cancer	2.34e-05	6.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GNG7—esophageal cancer	2.28e-05	6.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GAPDH—esophageal cancer	2.25e-05	5.98e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—esophageal cancer	2.24e-05	5.95e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CRABP1—esophageal cancer	2.23e-05	5.93e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HMOX1—esophageal cancer	2.21e-05	5.87e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDH2—esophageal cancer	2.13e-05	5.67e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—esophageal cancer	2.12e-05	5.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GNG7—esophageal cancer	2.12e-05	5.64e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NOS3—esophageal cancer	2.1e-05	5.59e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—EP300—esophageal cancer	2.07e-05	5.51e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—esophageal cancer	2.03e-05	5.39e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2A6—esophageal cancer	2.01e-05	5.33e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDH2—esophageal cancer	1.99e-05	5.28e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—esophageal cancer	1.97e-05	5.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS1—esophageal cancer	1.9e-05	5.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO1—esophageal cancer	1.9e-05	5.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.9e-05	5.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—esophageal cancer	1.89e-05	5.02e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PSME2—esophageal cancer	1.87e-05	4.98e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PSME1—esophageal cancer	1.87e-05	4.98e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2A6—esophageal cancer	1.87e-05	4.97e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO1—esophageal cancer	1.77e-05	4.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS1—esophageal cancer	1.77e-05	4.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.77e-05	4.7e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PSME2—esophageal cancer	1.75e-05	4.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PSME1—esophageal cancer	1.75e-05	4.64e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—esophageal cancer	1.74e-05	4.62e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—esophageal cancer	1.68e-05	4.47e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1B1—esophageal cancer	1.62e-05	4.29e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EP300—esophageal cancer	1.6e-05	4.25e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—esophageal cancer	1.53e-05	4.08e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP19A1—esophageal cancer	1.52e-05	4.04e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1B1—esophageal cancer	1.51e-05	4e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CREBBP—esophageal cancer	1.42e-05	3.77e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP19A1—esophageal cancer	1.42e-05	3.76e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—esophageal cancer	1.4e-05	3.7e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HMOX1—esophageal cancer	1.39e-05	3.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—esophageal cancer	1.36e-05	3.62e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—esophageal cancer	1.33e-05	3.54e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HMOX1—esophageal cancer	1.29e-05	3.43e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NOS3—esophageal cancer	1.27e-05	3.37e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—esophageal cancer	1.24e-05	3.3e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—esophageal cancer	1.18e-05	3.14e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—esophageal cancer	1.16e-05	3.09e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—esophageal cancer	1.15e-05	3.04e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—EP300—esophageal cancer	9.67e-06	2.57e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CREBBP—esophageal cancer	8.9e-06	2.36e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CREBBP—esophageal cancer	8.3e-06	2.2e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NOS3—esophageal cancer	7.97e-06	2.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NOS3—esophageal cancer	7.43e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—esophageal cancer	7.29e-06	1.94e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—esophageal cancer	7.15e-06	1.9e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—esophageal cancer	6.79e-06	1.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—EP300—esophageal cancer	6.06e-06	1.61e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—EP300—esophageal cancer	5.65e-06	1.5e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—esophageal cancer	4.48e-06	1.19e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—esophageal cancer	4.18e-06	1.11e-05	CbGpPWpGaD
